On 21-Jul-07 09:08:15, Rakesh Biswas wrote:
> Yes even I was wondering why it was posted to this list.
>
> rakesh
It is clearly a copy of a Press Release from "Jane McHugh,
Information Specialist" of the BMJ.
As such, it is designed to encouraged the Press to cite the BMJ.
I deleted it. People on our list who are interested in the
subject would already have been aware of the BMJ article, and
do not need it shoved under their noses.
On lists which I run, people are welcome to publicise things
which are useful to list subscribers and which they might not
otherwise be aware of, so long as this is done in a helpful
spirit. But anyone who joined the list for the purpose of
getting yet another outlet for their own publicity would be
taken off.
Ted.
> On 7/21/07, k.hopayian <[log in to unmask]> wrote:
>>
>> This looks like a commercial posting. It does not add to the
>> discussion on EBP, add to our understanding of it or ask/contribute
>> to collaboration. I would like to know what others on this list
>> think about such postings.
>>
>>
>> --
>> B/W, Kev Hopayian
>> -------on 20/7/07 11:14, Jane McHugh at [log in to unmask] wrote:
>>
>> *Evidence still lacking on how fast antidepressants act*
>>
>> One of the most important questions about antidepressant drugs - how
>> quickly they act - remains unanswered, say mental health experts
>> today.
>>
>> In an editorial for BMJ Clinical Evidence, Andrea Cipriani and
>> colleagues
>> say that the speed people respond to these drugs has great clinical
>> relevance for both the patient and the physician, but conclusive
>> evidence is
>> still lacking.
>>
>> For instance, a shorter response time rapidly improves patient
>> wellbeing,
>> decreasing length of hospitalisation, and reducing the amount of time
>> the
>> patient spends away from work, and the time the impairment affects
>> family
>> and friends. It also enables physicians to make prompt decisions about
>> changing or optimising treatment.
>>
>> Views have changed over the years, but recent studies indicate that
>> these
>> drugs act quickly rather than having a delayed effect.
>>
>> However, there are many challenges involved in designing studies to
>> detect
>> timing of onset, say the authors. For example, how to measure and
>> define an
>> early response and what degree of symptom reduction is needed to
>> fulfil this
>> definition.
>>
>> They also point to financial incentives surrounding fast acting
>> antidepressants, and warn clinicians to ensure that fast onset of
>> action is
>> not valued at the expense of tolerability or long-term effectiveness
>> of
>> antidepressant treatment.
>>
>> Ends
>> *
>> Note to editors:*
>> BMJ Clinical Evidence is an international peer reviewed medical
>> journal,
>> published by the BMJ Group. In addition, BMJ Clinical Evidence
>> provides an
>> invaluable set of evidence based medicine facilities to help busy
>> clinicians
>> manage their patients as effectively as possible. It sums up what's
>> known -
>> and not known - about more than 3000 interventions and 540 clinical
>> questions and is one of the world's most trusted and effective sources
>> of
>> medical evidence for clinical decisions.
>>
>> Further information from:
>> Shannon Amoils, Clinical Editor, BMJ Clinical Evidence
>> Tel: 0207 383 6737
>> Email: [log in to unmask]
>> *www.clinicalevidence.co.uk* <www.clinicalevidence.co.uk
>> www.clinicalevidence.co.uk>
>>
>> Click here to view full editorial: *
>> http://press.psprings.co.uk/bmj/july/Cipriani.doc*
>> <http://press.psprings.co.uk/bmj/july/Cipriani.doc><http://press.psprin
>> gs.co.uk/bmj/july/Cipriani.doc>
>>
>> ----------------------------------------------------
>> Jane McHugh, Information Specialist
>> BMJ Knowledge, BMJ Group
>> BMA House, Tavistock Square, London WC1H 9JR
>> Tel: 020 7383 6384 Fax: 020 7383 6242
>>
>> http://www.clinicalevidence.com
>> http://www.besttreatments.co.uk
--------------------------------------------------------------------
E-Mail: (Ted Harding) <[log in to unmask]>
Fax-to-email: +44 (0)870 094 0861
Date: 21-Jul-07 Time: 11:20:02
------------------------------ XFMail ------------------------------
|